Difference between revisions of "BioNLP 2023"
Line 1: | Line 1: | ||
[[SIGBIOMED]] | [[SIGBIOMED]] | ||
− | = | + | <font size="4"><b>BIONLP 2017</b></font> |
An ACL 2017 Workshop associated with the SIGBIOMED special interest group, featuring an associated task: BioASQ ( http://www.bioasq.org/) | An ACL 2017 Workshop associated with the SIGBIOMED special interest group, featuring an associated task: BioASQ ( http://www.bioasq.org/) |
Revision as of 03:26, 16 February 2017
BIONLP 2017
An ACL 2017 Workshop associated with the SIGBIOMED special interest group, featuring an associated task: BioASQ ( http://www.bioasq.org/)
Vancouver, Canada, Friday August 4, 2017
IMPORTANT DATES
- Submission deadline: Friday April 21, 2017 11:59 PM Eastern US
- Notification of acceptance: Friday May 19, 2017
- Camera-ready copy due from authors: Friday May 26, 2017
- Workshop: Friday August 4, 2017
SUBMISSION INSTRUCTIONS
Two types of submissions are invited: full papers and short papers. Submissions are due by 11:59 PM EST on Friday April 21, 2017.
Full papers should not exceed eight (8) pages of text, plus unlimited references. These are intended to be reports of original research. BioNLP aims to be the forum for interesting, innovative, and promising work involving biomedicine and language technology, whether or not yielding high performance at the moment. This by no means precludes our interest in and preference for mature results, strong performance, and thorough evaluation. Both types of research and combinations thereof are encouraged.
Short papers may consist of up to four (4) pages of content, plus unlimited references. Appropriate short paper topics include preliminary results, application notes, descriptions of work in progress, etc.
Electronic Submission Submissions must be electronic and in PDF format, using the Softconf START conference management system at https://www.softconf.com/acl2017/bionlp/ We strongly recommend the use of ACL LaTeX style files tailored for this year's conference. Submissions must conform to the official style guidelines. Style files and other information about paper formatting requirements are available on the conference website, http://acl2017.org/.
Submissions need to be anonymous.
Dual submission policy: papers may NOT be submitted to the BioNLP 2017 workshop if they are or will be concurrently submitted to another meeting or publication.
WORKSHOP OVERVIEW AND SCOPE
Over the course of the past fifteen years, the ACL BioNLP workshop associated with the SIGBIOMED special interest group has established itself as the primary venue for presenting foundational research in language processing for the biological and medical domains. The workshop serves as both a venue for bringing together researchers in bio- and clinical NLP and exposing these researchers to the mainstream ACL research, and a venue for informing the mainstream ACL researchers about the fast growing and important domain. The workshop will continue presenting work on a broad and interesting range of topics in NLP.
The active areas of research include, but are not limited to:
- Entity identification and normalization for a broad range of semantic categories
- Extraction of complex relations and events
- Semantic parsing
- Discourse analysis
- Anaphora /Coreference resolution
- Text mining
- Literature based discovery
- Summarization
- Question Answering
- Resources and novel strategies for system testing and evaluation
- Infrastructures for biomedical text mining
- Processing and annotation platforms
- Translating NLP research to practice
- Theoretical underpinnings of biomedical language processing
- Research Reproducibility
Organizers:
Kevin Bretonnel Cohen, University of Colorado School of Medicine Dina Demner-Fushman, US National Library of Medicine Sophia Ananiadou, National Centre for Text Mining and University of Manchester, UK Jun-ichi Tsujii, National Institute of Advanced Industrial Science and Technology, Japan and University of Manchester, UK
ACL Anti-Harassment Policy
https://www.aclweb.org/adminwiki/index.php?title=Anti-Harassment_Policy
If you have any concerns or experience harassment or hostile behavior please contact Dina Demner-Fushman, Kevin Bretonnel Cohen or any current member of the ACL Executive Committee.